GBA1 and Parkinson disease: PD patients with GBA1 mutations exhibit a threefold increased risk of cognitive decline, affecting working memory, executive and visuospatial functions (Alcalay et al. 2012; Zokaei et al. 2014; Mata et al. 2016; Leocadi et al. 2022).